Paperonium

← Back to the plain-language case

Abstract swaps which CEACAM1 variant the Results report as strongly overexpressed in lung tumors

Nucleic Acids Res (2008) · doi:10.1093/nar/gkn697 · PMC2582617

Summary

The abstract states "overexpression of CEACAM1 variant 1 but not variant 2 in lung tumors". The paper's Results report the opposite emphasis for the same 35 paired lung adenocarcinomas: variant 2 was "highly and significantly overexpressed" (tumor/normal ratio 36.42, P = 0.000002), and variant 1 was "only slightly overexpressed" (ratio 3.53, P = 0.0014). By the paper's own numbers both variants are significantly higher in tumor, and the variant 2 ratio is 10.3 times the variant 1 ratio. The exon-array pattern, the survival hypothesis in the Results and the Discussion's "switch in abundance from the L form (variant 1) to the S form (variant 2)" all point the same way as the Results. The abstract therefore misstates which CEACAM1 isoform rises in lung tumors. This matters because the paper presents the isoforms as having different biology, with the L form described as tumor-suppressive.

What the paper reports

Abstract:

We found overexpression of ERG variant 2 but not variant 1 in lung tumors and overexpression of CEACAM1 variant 1 but not variant 2 in lung tumors but not in breast or colon tumors.

Results, "Quantification of CEACAM1 transcript variants in NSCLC", first paragraph (variant definitions and exon-array pattern):

CEACAM1 is encoded by nine exons with two known variants in the RefSeq database. Variant 1 uses all nine exons while variant 2 is missing exon 7 (Figure 4c). Our array data demonstrated higher expression of exons 1 through 6 as well as 8 and 9 in tumors versus normal while expression of exon 7 was essentially equal (Supplementary Figures).

Results, same section, second paragraph (variant-specific qRT-PCR):

In 35 lung adenocarcinoma patients we found that CEACAM1 variant 2 was highly and significantly overexpressed in paired tumor versus normal (tumor/normal ratio = 36.42; P = 0.000002) while variant 1 was only slightly overexpressed in tumor (tumor/normal ratio = 3.53; P = 0.0014).

In the breast and colon tissues however, we found no significant differences in expression of either variant 1 or variant 2 in tumor versus normal (unmatched) samples (Figure 4b).

Given this data we postulated that overexpression of CEACAM1 variant 2 in lung cancer may be responsible for the survival differences observed between tumor types.

Figure 4 legend, panel (c):

Exon location and PCR primers locations for qPCR of variant 1 (NM_001712; primers 1 and 2), variant 2 (NM_001024912; primers 3 and 4).

Discussion, CEACAM1 paragraph:

Two common variants are known for CEACAM1; one with a long cytoplasmic domain (L form or variant 1) and one with a short cytoplasmic domain (S form or variant 2).

Our quantitative analysis clearly demonstrates a switch in abundance from the L form (variant 1) to the S form (variant 2) in NSCLC and we also demonstrate that no such switch appears to occur in breast cancer or colon cancer.

For comparison, the ERG clause of the same abstract sentence against its own Results ("Differential expression of ERG splice variants in lung adenocarcinoma"):

We observed that ERG variant 2 was significantly overexpressed (mean tumor/normal ratio 4.73; paired t-test P-value = 0.0005) in tumor samples compared to paired normal while ERG variant 1 was slightly under-expressed in tumor samples compared to normal (ratio = 0.74; P = 0.0186).

What the paper's own numbers show

Method. The individual qPCR measurements are not published, so the paired tests cannot be re-run. The check reads the reported tumor/normal ratios and P-values against the abstract's statement. A variant counts as "overexpressed" when its ratio is above 1 and P < 0.05, the threshold the paper uses throughout. I then compared the size of the two CEACAM1 changes (ratio of ratios and log2 fold change), checked which variant the exon-array pattern implies, and ran the same check on the ERG clause in the same abstract sentence as a control. Every number below is printed by recompute.py.txt.

Quantity Location Reported Recomputed from the paper's numbers
CEACAM1 variant 2 (S form, lacks exon 7), lung, 35 pairs Results, CEACAM1 section; Fig. 4a ratio 36.42, P = 0.000002 log2 fold change +5.19; −log10 P = 5.70; significantly overexpressed. The abstract says "not variant 2": conflicts
CEACAM1 variant 1 (L form, all nine exons), lung, 35 pairs Results, CEACAM1 section; Fig. 4a ratio 3.53, P = 0.0014 ("only slightly overexpressed") log2 fold change +1.82; −log10 P = 2.85; significantly overexpressed. The abstract says overexpressed: agrees
Size of the variant 2 change relative to variant 1 Results, CEACAM1 section not stated 36.42 / 3.53 = 10.32 (log2 difference 3.37); P-values differ by a factor of 700
Exon-array pattern Results, CEACAM1 section, first paragraph exons 1–6, 8, 9 higher in tumor; exon 7 "essentially equal" exon 7 occurs only in variant 1, so a flat exon 7 with rising shared exons points to a rise in variant 2: agrees with the Results, not with the abstract
Direction stated elsewhere Results (survival hypothesis); Discussion "overexpression of CEACAM1 variant 2"; "switch … from the L form (variant 1) to the S form (variant 2)" both say variant 2 rises in lung tumors
Breast and colon, both variants Results; Fig. 4b no significant difference consistent with the abstract's "but not in breast or colon tumors"
ERG variant 2, lung, 35 pairs (control) Results, ERG section ratio 4.73, P = 0.0005 log2 +2.24; significantly overexpressed. The abstract says overexpressed: agrees
ERG variant 1, lung, 35 pairs (control) Results, ERG section ratio 0.74, P = 0.0186 log2 −0.43; significantly under-expressed. The abstract says not overexpressed: agrees

The ratio of ratios compares the size of each variant's tumor/normal change. It does not compare the absolute abundance of the two transcripts.

Figure

The abstract's CEACAM1 statement beside the Results and Discussion, with the reported ratios and the variant labels swapped between them

Figure 1. The left panel holds the abstract's CEACAM1 clause and what it states for lung tumors. The right panel holds the Results and Discussion sentences and the variant-specific tumor/normal ratios with their P-values, as printed (orange). The connector marks the conflict: the abstract names variant 1 as the overexpressed isoform and excludes variant 2, while the body reports variant 2 as the strongly overexpressed isoform. The blue lines are read from the paper's own numbers. Both variants have P < 0.05, the variant 2 ratio is 10.3 times the variant 1 ratio, and the exon-array pattern also points to variant 2.

Reported tumor/normal ratios for CEACAM1 and ERG variants on a log axis, each checked against the abstract's statement

Figure 2. Tumor/normal expression ratios reported in the Results for the 35 paired lung samples (orange dots, log scale; the thin vertical line at 1 means no change), with the reported P-values. The right column gives what the abstract says for each variant and whether that agrees with the reported ratio and P-value (blue; overexpressed means ratio > 1 and P < 0.05). Three of the four clauses in the abstract sentence agree with the body. The one that conflicts is the statement that CEACAM1 variant 2, the variant with the largest and most significant increase, is not overexpressed.

Why it matters

Explanations considered

Status

As of 2026-10-24:

Suggested correction

In the abstract, change the CEACAM1 clause so that it names the variant reported in the Results, Figure 4 and the Discussion, for example:

We found overexpression of ERG variant 2 but not variant 1 in lung tumors and overexpression of CEACAM1 variant 2 but not variant 1 in lung tumors but not in breast or colon tumors.

Because variant 1 was also significantly, though modestly, overexpressed (3.53-fold, P = 0.0014), a more exact wording would be "marked overexpression of CEACAM1 variant 2 (S form), with only slight overexpression of variant 1 (L form), in lung tumors but not in breast or colon tumors". No change to the numbers, figures or Discussion appears to be needed.